ENTRY       D12631                      Drug
NAME        Tobevibart (USAN/INN)
FORMULA     C6356H9846N1698O1988S42
EXACT_MASS  143112.9822
MOL_WEIGHT  143201.1002
SEQUENCE    (Heavy chain)
            ELQLVESGGG WVQPGGSQRL SCAASGRIFR SFYMSWVRQA PGKGLEWVAT INQDGSEKLY
            VDSVKGRFTI SRDNAKNSLF LQMNNLRVED TAVYYCAAWS GNSGGMDVWG QGTTVSVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLAGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PLPEEKTISK AKGQPREPQV YTLPPSRDEL
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVL HEALHSHYTQ KSLSLSPGK
            (Light chain)
            SYELTQPPSV SVSPGQTVSI PCSGDKLGNK NVAWFQHKPG QSPVLVIYEV KYRPSGIPER
            FSGSNSGNTA TLTISGTQAM DEAAYFCQTF DSTTVVFGGG TRLTVLGQPK AAPSVTLFPP
            SSEELQANKA TLVCLISDFY PGAVTVAWKA DSSPVKAGVE TTTPSKQSNN KYAASSYLSL
            TPEQWKSHRS YSCQVTHEGS TVEKTVAPTE CS
            (Disulfide bridge: H22-H96, H146-H202, H222-L211, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'211, H'263-H'323, H'369-H'427, L22-L87, L134-L193, L'22-L'87, L'134-L'193)
  TYPE      Peptide
EFFICACY    Antiviral
  TYPE      Monoclonal antibody
COMMENT     Treatment of chronic HBV infection and chronic HBV and HDV coinfection
TARGET      HBV surface antigen [KO:K23128]
  PATHWAY   ko03230(K23128)  Viral genome structure
            ko05161(K23128)  Hepatitis B
BRITE       Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Hepatitis virus antigen
                D12631  Tobevibart (USAN/INN)
DBLINKS     CAS: 2645440-65-7
///
